沈陳林
發(fā)布時(shí)間:2025-03-08

 

沈陳林,校聘副教授


研究方向:肽分子自組裝藥物遞送系統(tǒng),電化學(xué)生物傳感,中藥配伍機(jī)制及中藥藥代動(dòng)力學(xué),腫瘤早期診斷


電子郵箱:shchlin520@163.com


辦公室:知行樓1215室


教育經(jīng)歷:

(1) 2013/09-2016/07, 安徽醫(yī)科大學(xué),藥學(xué)院,博士,生物藥劑專業(yè)

(2) 2010/09-2013/07, 安徽醫(yī)科大學(xué),藥學(xué)院,碩士,定量藥理與臨床藥代動(dòng)力學(xué)專業(yè)

(3) 2001/09-2006/07, 安徽醫(yī)科大學(xué),藥學(xué)院,學(xué)士,臨床藥理專業(yè)


工作經(jīng)歷:

(1) 2016/07-2024/12  安徽醫(yī)科大學(xué),藥學(xué)院,校聘副教授

(2) 2024/12-至今  安徽醫(yī)科大學(xué),藥學(xué)科學(xué)學(xué)院,校聘副教授


學(xué)術(shù)兼職:

(1)安徽省藥學(xué)會(huì)藥物代謝專業(yè)委員會(huì)委員

(2)安徽省執(zhí)業(yè)藥師協(xié)會(huì)治療藥物監(jiān)測(cè)藥師分會(huì)委員

(3)中國(guó)CRC專家安徽分會(huì)委員

(4)安徽藥師協(xié)會(huì)居家藥學(xué)服務(wù)藥師分會(huì)委員


科研項(xiàng)目:

(1)國(guó)家自然科學(xué)基金委員會(huì),青年項(xiàng)目,H2816,基于苦杏仁苷立體選擇性吸收和脫氨代謝途徑的麻黃-杏仁藥對(duì)配伍減毒的機(jī)制研究,2018-01至2020-12,20萬,結(jié)題,參與。

(2)國(guó)家自然科學(xué)基金委員會(huì),青年項(xiàng)目,81800606,基于線粒體自噬探討脂聯(lián)素抑制腎小管上皮細(xì)胞程序性死亡的機(jī)制,2019-01至2021-12月,21萬元,結(jié)題,參與。

(3)基于MDCK-HPLC聯(lián)用技術(shù)的四物湯中有效成分梓醇、阿魏酸、芍藥苷和川芎嗪吸收研究及其機(jī)制探討(0601069201),2017-01至2019-12月,2.0萬元,結(jié)題,主持。

(4)8-叔丁胺基甲基橙皮素(MTBH)在MRP2膜囊泡上轉(zhuǎn)運(yùn)機(jī)制及其對(duì)CYP450 3A4和2E1的影響(0601069101),2017-01至2019-12月,4.0萬元,結(jié)題,主持。

(5)多柔比星脂質(zhì)體的體內(nèi)、外評(píng)價(jià),江蘇長(zhǎng)泰藥業(yè)有限公司合作項(xiàng)目2022(0601069202),2022-04至2025-04,5.0萬元,在研,主持。

(6)萬古霉素肽載體遞藥系統(tǒng)在顱內(nèi)感染應(yīng)用和治療(0601001853),學(xué)科建設(shè)經(jīng)費(fèi),2022-05至2025-05,5.0萬元,在研,主持。

(7)紫鉚因及其代謝產(chǎn)物抗腫瘤機(jī)制研究(0601023425),省立醫(yī)院作項(xiàng)目,2023-05至2025-05,10.0萬元,在研,主持。


發(fā)表論文情況:

1.You Y, Ren Y, Li Y, Xu J, Li Z, Song S, Xia J, Shen C, Wang J. Interface-constrained catalytic hairpin assembly permits highly sensitive SERS signaling of miRNA.Mikrochim Acta. 2024 May 10;191(6):321. (IF: 5.339)

2.Chang W, Wang J, You Y, Wang H, Xu S, Vulcano S, Xu C, Shen C, Li Z, Wang J. Triptolide Reduces Neoplastic Progression in Hepatocellular Carcinoma by Downregulating the Lipid Lipase Signaling Pathway.Cancers (Basel). 2024 Jan 27;16(3):550. (IF: 4.574)

3.Zhu R#, Jiang H#, Li C, Li Y, Peng M, Wang J, Wu Q, Yan C, Bo Q, Wang J*, Shen C*, Qin P*. CRISPR/Cas9-based point-of-care lateral flow biosensor with improved performance for rapid and robust detection of Mycoplasma pneumonia. Anal Chim Acta. 2023 May 29; 1257:341175. (IF: 6.911)

4.Wang S, Wen Q, Qin Y, Xia Q, Shen C, Song S. Gut microbiota and host cytochrome P450 characteristics in the pseudo germ-free model: co-contributors to a diverse metabolic landscape.Gut Pathog. 2023 Mar 21;15(1):15. (IF: 4.316)

5.Wang J#, Sun J#, Zhang J, Shen C*, Zhang X, Xu J*. Engineered G-Quadruplex-Embedded Self-Quenching Probes Regulate Single Probe-Based Multiplex Isothermal Amplification to Light Road Lamp Probes for Sensitized Determination of microRNAs. Anal Chem. 2022 Mar 15;94(10). (IF: 8.008)

6.Wen Q, Yu S, Wang S, Qin Y, Xia Q, Wang S, Chen G, Shen C*, Song S*. Impact of intestinal microbiota on metabolic toxicity and potential detoxification of amygdalin. Front Microbiol. 2022 Nov 24;13. (IF: 6.064)

7.Wu J, Fan Y, Zheng L, Wang Z, Liu Y, Shen C*, Hu W. An Open-Label, Randomized Pharmacokinetic Study of 2 Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions. Clin Pharmacol Drug Dev. 2022 Nov;11(11):1322-1330. (IF: 2.114)

8.Wang S, Qin Y, Wen Q, Xia Q, Gu R, Wang S, Chen G, Tan C, Shen C*, Song S*. Intestinal microbiota-mediated biotransformations alter the pharmacokinetics of the major metabolites of azathioprine in rats after oral administration. Drug Metab Pharmacokinet. 2022 Aug;45. (IF: 2.7)

9.Qin Y, Wang S, Wen Q, Xia Q, Wang S, Chen G, Sun J, Shen C*, Song S*. Interactions Between Ephedra sinica and Prunus armeniaca: From Stereoselectivity to Deamination as a Metabolic Detoxification Mechanism of Amygdalin.Front Pharmacol. 2021 Nov 26;12:744624. (IF: 5.988)

10.Qin Y, Dong H, Sun J, Zhang Y, Li J, Zhang T, Chen G, Wang S, Song S, Wang W, Fan Y, Wang J, Huang X, Shen C*. Evaluation of MTBH, a novel hesperetin derivative, on the activity of hepatic cytochrome P450 isoform in vitro and in vivo using a cocktail method by HPLC-MS/MS. Xenobiotica. 2021 Dec;51(12):1389-1399. (IF: 1.997)

11.Shen C; Chen R; Qian Z; Meng X; Hu T; Li Y; Chen Z; Huang C; Hu C; Li J*; Intestinal absorption mechanisms of MTBH, a novel hesperetin derivative, in Caco-2 cells, and potential involvement of monocarboxylate transporter 1 and multidrug resistance protein 2,Eur J Pharm Sci, 2015 Oct 12, 78: 214-24. (IF: 3.773)

12.Shen C, Jin X, Wu M, Huang X, Li J, Huang H, Li F, Liu J, Rong G, Song S. A sensitive LC-MS/MS method to determine ginkgolide B in human plasma and urine: application in a pharmacokinetics and excretion study of healthy Chinese subjects. Xenobiotica. 2020 Mar;50(3):323-331.(IF: 1.908)


發(fā)表專利情況:

一種同時(shí)測(cè)定人血漿中利多卡因及丁卡因濃度的方法,2023-04


饶河县| 许昌市| 武城县| 汾阳市| 茂名市| 花垣县| 宜良县| 武清区| 阜新市| 图木舒克市| 抚远县| 金门县| 武宁县| 密云县| 富蕴县| 泊头市| 尼勒克县| 禹城市| 栾城县| 探索| 拉萨市| 千阳县| 永平县| 新津县| 乡宁县| 九龙城区| 福泉市| 祁东县| 信阳市| 南靖县| 定边县| 米易县| 凉城县| 孝感市| 甘南县| 布尔津县| 内乡县| 敖汉旗| 珠海市| 定西市| 茌平县|